Jim Lines
Analyst · Bill Baldwin with Baldwin Anthony Securities
Thank you, Jeff. Good morning. We appreciate everyone joining our second quarter earnings conference call today. I will begin my remarks on Slide 9. Overall, as Jeff noted, sales in the quarter were up 24% compared to a year earlier. Definitely, orders improved about 1 year back, and that now was reflected as a recovery in quarterly sales. We’ve discussed a number of times during previous calls that when refining markets came out of the downturn, spending on existing facilities would occur before new capacity investment. three factors are relevant when considering the importance of that view. First is that Graham has a rather large installed base throughout North America, and in the Middle East, Asia and in Latin America. Second is that the original equipment supplier often is preferred for retrofit or replacement, as that supplier knows precisely how the existing equipment was designed. And third is these investments move quickly, and not as slowly as new capacity investment. Replacement equipment, bid opportunities maybe in our bid pipeline for just a few months, whereas new capacity bidding could be in the pipeline for more than a few years. Approximately 75% of the $9.7 million of sales to the refining industry during the quarter, were derived from the installed base, which highlights the significance of investment in the refining installed base, and how Graham is positioned to benefit from these investments. Another beneficial consideration is retrofit and replacement work has a higher margin potential than will most new capacity investment. Turning to chemical industry sales. While sales were down $1.9 million compared to last year, we consider that to be timing. The chemical industry is active. Here too, there can be retrofit or replacement sales along with new capacity sales. We do, however, view the chemical industry as a whole differently and that it is more about new capacity. However, for North America, with low cost natural gas as a primary feedstock, we are seeing from our installed base retrofit and replacement orders as chemical plants restart, revamp and expand existing facilities, implying sales to this sector will improve in the coming quarters. Sales into the power industry were flat, while sales to our other markets that include defense were up 18%. There is still a heavier weighting toward domestic sales due to the U.S. refineries commitment to improve their existing operating assets, low cost natural gas in the U.S., burning capacity expansions in the chemical industry and, of course, our Navy work is domestic. We should expect this trend to continue where greater than 50% of sales are for domestic markets. Please move on to Slide 10. The trailing 12-month new order trend of $140 million is encouraging, although it is impacted by two back-to-back $40 million bookings quarters. If we were to annualize the last two quarters, that would imply a 12 month bookings level of $112 million. Due to the size of certain orders, it is difficult to model a bookings run rate. On a qualitative basis, I can state, however, that the bookings environment today is superior to 18 to 24 months back. Again, refining industry new orders were strong with a combination of orders for new capacity and for those derived from the installed base. Chemical industry orders were up nicely, driven by orders that are for new capacity in the US Gulf Coast. Let’s now discuss backlog and details provided on Page 11. As Jeff said, we have a record backlog at just under $128 million. It sets up nicely fiscal 2020 for year-on-year growth. Importantly, refining industry backlog is up $20 million from this time last year, and similarly, chemical industry backlog is up approximately $15 million. It is encouraging to have a strong high-quality backlog from our traditional refining and chemical markets that is complemented by our large Navy backlog. Additionally, backlog conversion spans several years with 55% to 60% of backlog converting to sales within the next 12 months and 25% to 35% converting beyond two years from now. Turning to guidance for the remainder of the year, I ask that you refer to Page 12. Full year revenue guidance has narrowed to $98 million to $105 million. Gross margin is expected to range between 25% and 27%. Our SG&A spend will fall between $18.5 million and $18.75 million and our effective tax rate for the year is projected to be approximately 20%. The focus our team has had during the downturn on improving execution capability, along with effectively managing our bid pipeline enabled us to deliver 25% to 35% top line growth in 2019 compared to 2018, and also to have a strong backlog setting up 2020 as another growth year. I commend the Graham team for their impact on improving the company. Activity on the M&A front is providing a number of high-quality strategic fit targets that would expand our addressable market, leverage Graham sales channels or diversify revenue opportunities into less cyclical end markets. We are, however, finding these targets to be expensive and to have challenging risk-adjusted returns. Management and its Board of Directors are committed to putting our balance sheet to work to expand and diversify the company and we will stay disciplined about valuing deploying capital for growth. Jen, I would ask you to please open the line for questions. Thank you.